| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |